Cheol‐In Kang
Impact in
- Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 97
-
- Antimicrobial Resistance in Staphylococcus 41
- SARS-CoV-2 and COVID-19 Research 18
- Antifungal resistance and susceptibility 15
- Co-authors
- Kyong Ran Peck (230 shared papers)Doo Ryun Chung (224 shared papers)Jae‐Hoon Song (101 shared papers)Kang Won Choe (24 shared papers)Myoung‐don Oh (24 shared papers)Hong Bin Kim (22 shared papers)Eui-Chong Kim (14 shared papers)Kwan Soo Ko (63 shared papers)
- Journals
- European Journal of Clinical Microbiology & Infectious Diseases (21 papers)Diagnostic Microbiology and Infectious Disease (18 papers)Journal of Infection (14 papers)International Journal of Antimicrobial Agents (13 papers)Journal of Korean Medical Science (12 papers)
- Partner nations
- South KoreaTaiwanChina
In The Last Decade
Cheol‐In Kang
303 papers receiving 9.7k citations
Cheol‐In Kang's Hit Papers
Peers
Comparison fields: 5 of 137
- Molecular Medicine 3.3k
- Applied Microbiology and Biotechnology 792
- Endocrinology 729
- Infectious Diseases 2.4k
- Critical Care and Intensive Care Medicine 356
Countries citing papers authored by Cheol‐In Kang
This map shows the geographic impact of Cheol‐In Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheol‐In Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheol‐In Kang more than expected).
Fields of papers citing papers by Cheol‐In Kang
This network shows the impact of papers produced by Cheol‐In Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheol‐In Kang. The network helps show where Cheol‐In Kang may publish in the future.
Co-authors
The 25 scholars most cited alongside Cheol‐In Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 308 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 576 | |
| 2 | 2003 | 498 | |
| 3 | 2011 | 332 | |
| 4 | 2012 | 300 | |
| 5 | 2011 | 267 | |
| 6 | 2016 | 252 | |
| 7 | Challenges of Convalescent Plasma Infusion Therapy in Middle East Respiratory Coronavirus Infection: A Single Centre Experience Hit paper breakdown → | 2017 | 251 |
| 8 | 2004 | 231 | |
| 9 | 2007 | 225 | |
| 10 | 2018 | 161 | |
| 11 | 2004 | 160 | |
| 12 | 2008 | 159 | |
| 13 | 2009 | 151 | |
| 14 | 2013 | 142 | |
| 15 | 2003 | 119 | |
| 16 | 2011 | 119 | |
| 17 | 2011 | 113 | |
| 18 | 2016 | 110 | |
| 19 | 2016 | 110 | |
| 20 | 2006 | 106 |
About Cheol‐In Kang
Cheol‐In Kang is a scholar working on Molecular Medicine, Infectious Diseases, Epidemiology, Endocrinology and Applied Microbiology and Biotechnology, having authored 308 papers that have together received 10k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (97 papers), Antimicrobial Resistance in Staphylococcus (41 papers), Pneumonia and Respiratory Infections (24 papers), SARS-CoV-2 and COVID-19 Research (18 papers), Infections and bacterial resistance (17 papers), Neutropenia and Cancer Infections (15 papers), Antifungal resistance and susceptibility (15 papers) and Antibiotic Use and Resistance (15 papers). The work is most often cited by research in Molecular Medicine (3.3k citations), Applied Microbiology and Biotechnology (792 citations), Endocrinology (729 citations), Infectious Diseases (2.4k citations) and Critical Care and Intensive Care Medicine (356 citations). Cheol‐In Kang has collaborated with scholars based in South Korea, Taiwan and China. Frequent co-authors include Kyong Ran Peck, Doo Ryun Chung, Jae‐Hoon Song, Kang Won Choe, Myoung‐don Oh, Hong Bin Kim, Eui-Chong Kim, Kwan Soo Ko, Sung‐Han Kim and Nam Yong Lee. Their work appears in journals such as European Journal of Clinical Microbiology & Infectious Diseases, Diagnostic Microbiology and Infectious Disease, Journal of Infection, International Journal of Antimicrobial Agents and Journal of Korean Medical Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.